Home/Filings/4/0001707925-24-000080
4//SEC Filing

White Matthew J 4

Accession 0001707925-24-000080

CIK 0001707925other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 9:58 PM ET

Size

38.6 KB

Accession

0001707925-24-000080

Insider Transaction Report

Form 4
Period: 2024-03-11
White Matthew J
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2024-03-11+9,78067,414 total
  • Exercise/Conversion

    Ordinary Shares

    2024-03-11+5,35068,231.947 total
  • Award

    Performance Share Units

    2024-03-11+5,3505,350 total
    Exercise: $0.00Ordinary Shares (5,350 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-113,2600 total
    Exercise: $0.00Ordinary Shares (3,260 underlying)
  • Award

    Performance Share Units

    2024-03-11+9,7809,780 total
    Exercise: $0.00Ordinary Shares (9,780 underlying)
  • Tax Payment

    Ordinary Shares

    2024-03-11$462.55/sh4,532.053$2,096,30162,881.947 total
  • Tax Payment

    Ordinary Shares

    2024-03-11$462.55/sh2,479.191$1,146,75065,752.756 total
  • Exercise/Conversion

    Ordinary Shares

    2024-03-11+3,26069,012.756 total
  • Tax Payment

    Ordinary Shares

    2024-03-11$462.55/sh1,510.685$698,76767,502.071 total
  • Exercise/Conversion

    Performance Share Units

    2024-03-119,7800 total
    Exercise: $0.00Ordinary Shares (9,780 underlying)
  • Exercise/Conversion

    Performance Share Units

    2024-03-115,3500 total
    Exercise: $0.00Ordinary Shares (5,350 underlying)
Holdings
  • Restricted Stock Units

    Ordinary Shares (2,870 underlying)
    2,870
  • Restricted Stock Units

    Exercise: $0.00Ordinary Shares (2,600 underlying)
    2,600
  • Stock Option (right to buy)

    Exercise: $354.14From: 2024-03-07Exp: 2033-03-07Ordinary Shares (18,970 underlying)
    18,970
  • Stock Option (right to buy)

    Exercise: $253.68From: 2022-03-08Exp: 2031-03-08Ordinary Shares (34,320 underlying)
    34,320
  • Stock Option (right to buy)

    Exercise: $118.71From: 2018-02-28Exp: 2027-02-28Ordinary Shares (72,795 underlying)
    72,795
  • Deferred Stock Units

    Ordinary Shares (1,375.758 underlying)
    1,375.758
  • Restricted Stock Units

    Ordinary Shares (2,625 underlying)
    2,625
  • Stock Options (right to buy)

    Exercise: $465.29From: 2025-03-07Exp: 2034-03-07Ordinary Shares (17,015 underlying)
    17,015
  • Stock Options (right to buy)

    Exercise: $270.99From: 2023-03-07Exp: 2032-03-07Ordinary Shares (22,535 underlying)
    22,535
  • Stock Option (right to buy)

    Exercise: $176.63From: 2020-03-20Exp: 2029-03-20Ordinary Shares (47,020 underlying)
    47,020
  • Stock Option (right to buy)

    Exercise: $154.00From: 2019-02-27Exp: 2028-02-27Ordinary Shares (64,665 underlying)
    64,665
Footnotes (16)
  • [F1]Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 8, 2021.
  • [F10]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
  • [F11]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
  • [F12]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
  • [F13]This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
  • [F14]This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
  • [F15]Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.
  • [F16]Deferred stock units acquired under the Linde Compensation Deferral Plan ("Plan"). The deferred stock units will payout in Linde plc Ordinary Share on a one-for-one basis in accordance with the Plan.
  • [F2]Ordinary shares withheld from the payout to cover tax withholdings.
  • [F3]Ordinary shares acquired pursuant to the payout of a restricted stock unit grant made on March 8, 2021.
  • [F4]The PSU paid out on March 11, 2024 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2021-2023 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2021.
  • [F5]The PSU paid out on March 11, 2024 and the number of shares awarded and paid out was determined based upon the average annual total shareholder return ("TSR") of Linde plc from 2021-2023 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2021.
  • [F6]Restricted Stock Units that vested in full and paid out on March 11, 2024 in Linde plc Ordinary Shares on a one-for-one basis.
  • [F7]Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
  • [F8]Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.
  • [F9]Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis.

Issuer

LINDE PLC

CIK 0001707925

Entity typeother

Related Parties

1
  • filerCIK 0001441755

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 9:58 PM ET
Size
38.6 KB